Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENELOPE: Nesuparib and Pembrolizumab in pMMR Endometrial Cancer
NCT06502743Phase 2Recruiting
- Sponsor
- Yonsei University
- Start
- Sep 2024
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nesuparib in endometrial cancer (EC), sponsored by Yonsei University. Started Sep 2024; status: recruiting.
02
Drugs
nesuparib
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT06502743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06502743.